Black Swift Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$598K Sell
650
-250
-28% -$253K 0.1% 90
2025
Q4
$967K Sell
900
-75
-8% -$71.7K 0.16% 79
2025
Q3
$744K Sell
975
-225
-19% -$167K 0.13% 75
2025
Q2
$935K Sell
1,200
-697
-37% -$542K 0.19% 64
2025
Q1
$1.57M Buy
1,897
+752
+66% +$626K 0.35% 49
2024
Q4
$884K Sell
1,145
-4,225
-79% -$3.5M 0.19% 69
2024
Q3
$4.76M Sell
5,370
-1,998
-27% -$1.8M 1.05% 19
2024
Q2
$6.67M Buy
7,368
+518
+8% +$414K 1.54% 14
2024
Q1
$5.33M Buy
6,850
+2,000
+41% +$1.42M 1.37% 16
2023
Q4
$2.83M Sell
4,850
-3,150
-39% -$1.84M 0.85% 31
2023
Q3
$4.3M Buy
8,000
+5,325
+199% +$2.74M 1.4% 15
2023
Q2
$1.25M Buy
+2,675
New +$1.12M 0.43% 43
2019
Q1
Sell
-42
Closed -$5K 87
2018
Q4
$5K Hold
42
0.01% 40
2018
Q3
$5K Buy
+42
New +$4.2K ﹤0.01% 66

Other funds holding LLY

Black Swift Group's LLY Position: Q1 2026 in Review

Black Swift Group reduced its Eli Lilly (LLY) stake by 28% in Q1 2026, selling an estimated $253K and leaving 650 shares worth $598K. The position accounts for 0.1% of the portfolio, ranked #90.

Black Swift Group first reported a position in LLY in Q3 2018 and has held it in 14 quarters since. The position peaked at $6.67M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Black Swift Group held 650 shares of Eli Lilly worth $598K as of Q1 2026.
  • Black Swift Group sold 250 Eli Lilly shares in Q1 2026, an estimated $253K.
  • Eli Lilly made up 0.1% of Black Swift Group's portfolio in Q1 2026, its #90 holding.
  • Black Swift Group first reported a position in Eli Lilly in Q3 2018 and has held it in 14 quarters since.
  • Black Swift Group's Eli Lilly position peaked at $6.67M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Black Swift Group's 13F filing for Q1 2026, filed 24 Apr 2026.